MOLECULAR BIOLOGY /RECOMBINANT PROTEIN

分子生物学/重组蛋白

• 批准号: 7102524
• 负责人: PETER D. EMANUEL
• 金额: $ 6.63万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-04-28 至 2010-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7102524
• 关键词: biomedical facility; biotechnology; gene expression; molecular biology; neoplasm /cancer; neoplasm /cancer genetics; plasmids; polymerase chain reaction; protein purification; recombinant proteins; training

DESCRIPTION (provided by applicant): The Molecular Biology Core has been in operation for the past fourteen years and has provided state-of-the-art methodologies for numerous molecular biological techniques and recombinant protein expression and purification. Operating funds for the Molecular Biology Core have come from the UAB CFAR and through a chargeback mechanism for services rendered. As the visibility and reputation of the Core has increased, the use by Comprehensive Cancer Center (CCC) members on non-CFAR projects have increased to approximately 50% of the Core activities. This is due in part to the success of CCC members for Breast and Brain Tumor SPORES and several joint program projects. To keep servicing the CCC members at an affordable cost, we are proposing to establish a joint CFAR/CCC Core with the following goals: Specific Aim 1: To train personnel (technology transfer) to assist in the various phases of plasmid construction, PCR, mutagenesis and expression/purification of recombinant proteins. Specific Aim 2: To provide the following contract services to CCC members at reduced costs: Plasmid DNA preparation, subcloning, recombinant protein expression, PCR and DNA mutagenesis. During the last fourteen years of operation, the Molecular Biology Core has assisted on average over twenty CCC members per year. The Core has averaged $40,000/year in chargebacks from CCC members. Most recently, the Core has provided expertise and service to CCC members engaged in Breast and Brain Tumor SPORE and joint programs projects between UAB and SRI designed to develop new suicide gene methods for cancer. We are requesting support for Core personnel to maintain the multi-disciplinary efforts to the Core and to keep costs affordable to all CCC members. The majority of the requested money then will be salary for key shared resource personnel (David McPherson) that is distinct from the supported CFAR Core personnel (Sylvia McPherson).

描述（由申请人提供）：分子生物学核心已经运行了 在过去的14年中，已经为许多分子生物学技术和重组蛋白表达和纯化提供了最先进的方法。 分子生物学核心的业务资金来自UAB CFAR，并通过所提供服务的收费机制。 随着核心的知名度和声誉的提高，综合癌症中心（CCC）成员在非CFAR项目中的使用已增加到核心活动的约50%。 这部分归功于CCC成员在乳腺和脑肿瘤孢子和几个联合计划项目上的成功。 为了以可承受的成本为CCC成员提供服务，我们建议建立一个CFAR/CCC联合核心，目标如下：具体目标1：培训人员（技术转让），以协助质粒构建，PCR，诱变和重组蛋白表达/纯化的各个阶段。具体目标二：以较低的成本向CCC成员提供以下合同服务：质粒DNA制备、亚克隆、重组蛋白表达、PCR和DNA诱变。 在过去14年的运作中，分子生物学核心平均每年帮助20多名CCC成员。 核心平均每年从CCC成员那里获得40，000美元的退款。 最近，该中心为从事乳腺和脑肿瘤孢子的CCC成员提供专业知识和服务，并为UAB和SRI之间旨在开发新的癌症自杀基因方法的联合计划项目提供服务。 我们请求支持核心人员，以维持核心的多学科努力，并使所有CCC成员都能负担得起费用。 然后，所请求的资金的大部分将是关键共享资源人员（大卫·麦克弗森）的工资，这与支持的CFAR核心人员（西尔维娅·麦克弗森）不同。